latest news:
04.04.2013:
ChromoTek’s fluorescent two hybrid (F2H®) technology enables screening and validation of compounds in living cells
more
04.04.2013:
Push For Smart Industry: ChromoTek wins category "Biotechnology" and the overall first prize from 1200 participating companies.
more
28.03.2013:
Visit us at the annual meeting of the American Association for Cancer Research, booth 1038!
more
18.03.2013:
ChromoTek's Chromobody® Technology for High Content drug profiling licensed to Bayer
more